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CHAPTER I 
INTRODUCTION 
The present study was conducted in order to evaluate the effects of 
chlorpromazine on certain aspects of visual functioning . The particular 
aspects of the sensory system which were selected for evaluation under 
drug were visual sensitivity and the effects produced in the visual 
sphere by stimulation of another sense modality . It has been observed 
that the simultaneous stimulation of one or more secondary sense 
modalities is associated with changes in the efficieney of function of 
a primary modality . This phenomenon of sensory interaction has been 
referred to in the literature as intersensory effects. The exact 
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nature and mechanism of the changes observed in the functioning of the 
primary sensory system has been under study for some time . Some investi-
gators reported improvement cril.y in the efficiency of function, while 
others found only impairment . Still others noted neither, or both types 
of effect . The most recent experiments suggest that the efficiency of 
the primary sensory system first increases and then decreases . This 
bipolar intersensory effect is associated with the intensity of the 
accessory stimulation. When the accessory stimulation is weak, facili-
tation of function is noted but as the secondary stimulation gets more 
intense, inhibition occurs . Recent evidence has indicated that these 
intersensory effects may be quite complex and that interactions probably 
occur among several systems operating simultaneously. These problems 
are still under investigation. 
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The drug selected for the present study was chlorpromazine. It was 
chosen from the broad group of new medicaments known commonly as the 
tranquilizers because of its wide clinical usage with psychiatric and 
medical patients. Some of the broad clinical actions, effects on 
psychiatric symptomotology, adverse side effects, and somatic responses 
to chlorpromazine have been well presented and documented in the litera-
ture. However, these well explored aspects represent only a portion of 
the actions of this drug. Despite the wide utilization of chlorproma-
zine in some areas of medical practice, little is known, for example, 
about the actual physiological actions which produce emotional t!nd 
behavioral changes in patients. It is thought to produce these changes 
by action on some aspects of the nervous system, but these sites and 
mechanisms of action are still obscure. Little also is known about the 
effects of chlorpromazine on sensory and perceptual process. Further, 
data on chlorpromazine effects on normal human functions are particularly 
scarce with the great bulk of existirg research having been done on 
patient populations . 
As a result, the present research was designed to explore chlorpro-
mazine's effect on visual and intersensory function in normals. The aim 
was to contribute to the body of knowledge about basic effects of chlor-
promazine on sensory function. To do this, the study was framed in terms 
of intersensory effects. This experimental phenomenon is well documented 
and has generated a b::>dy of knowledge within which to evaluate further 
research results. The method used in the present stuiy was a modifica-
tion of the psychophysical method of limits. The theoretical context of 
the study was a postulated structure referred to as the nmutually 
recruitable neurone,u (MRN) . This postulated structure has been used 
successfully to explain empirical intersensory effects . It was felt 
that an experimental study within the framework cited might provide 
clues to the modes of function of chlorpromazine, and would aid in 
the evaluation of drug effects on sensory processes . 
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CHAPTER II 
EFFECTS OF CHLORProMAZINE 
As a basis for interpreting the possible effects of chlorpromazine 
on sensory function, it was necessary to examine the recent research data 
and theories on the actions of the drug. The examination of the litera-
ture was executed in order to assemble relevant data bout the drug's 
action and to provide a basis for inference about the effect of chlorpro-
mazine on perception. As a result, researches in the areas of drug 
effect on physiological and neurological action were considered, ax were 
possible theories of chlorpromazine action. Studies of a more clinical 
and descriptive nature also w.ere evaluated. Finally, researches particu-
larly relevant to the focus of the present study, drug effects on 
perceptual and sensory processes, were examined. 
A. Physiological and Neurological Action 
Within the past ten years, chlorpromazine has gained prominence as 
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a tranquilizing agent. Smith, Kline & French Laboratories (1956), in a 
review which th~ published, identified the major drug effect as one of 
tranquilization without hypnosis. However, this effect is only one of 
many associated with this broad action drug. It is further reported that 
chlorpromazine increases the effectiveness of other depressant drugs, is a 
powerful anti-emetic, decreases body temperature and basal metabolic rate 
in proportion to the fall in temperature, and produces peripheral vaso-
dilation and fall in blood pressure. As a matter of fact, chlorpromazine 
was first used as a treatment for hypertension. other effects and uses 
reported include protection against hemorrhagic ani traumatic shock in 
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animals; reduction of pituitar,y secretion of ACTH, gonadotropins, and 
probably other hormones; reduction of gastric secretory volume; weak 
antihistaminic action; and, in high doses, depressant effects on respira-
tory function. Less clearly stated were the mechanisms for production 
of these effects and the site of action in the rervous system. It was 
concluded that tranquilization was 11 mediated via the brain stem 
reticular formation. 11 (p. 35) 
Site and mode of action of chlorpromazine ha. ve been further explored. 
Pennes (1957) reported that chlorpromazine depresses hypothalamic 
function. This structure is thought of as the co-ordinating center for 
the "fight-flight" reaction, arrl depression of this area might conceiva-
bly cause tranquilization. He further felt that chlorpromzine has 
direct cerebral cortical effect. Evidence was offered that certain 
conditioned reflexes are suppressed by doses which do not affect the 
unconditioned reflexes. Since the conditioned reflexes are cortically 
mediated, the central action of the drug was inferred. 
Himwich (1960) concurred in assuming cerebral cortex effects but 
felt that other effects are more important. He stated: 
• • • most potent actions are exerted on the sub-cortical 
structures regarded as parts of the anatomic substrate of 
emotion: the midbrain reticular formations, the hypothalamus, 
and the components of the rhinencephalon. (p. 59-60) 
Ayd (1956) theorized that the widespread action of the drug in 
areas of the brain is due to chlorpromazine 1 s influence on synaptic 
transmission of impulses in all parts of the central nervous system. 
Investigation into such a synaptic transmission theory was done b,y 
Marrazzi (1957, b). Using electrical stimulation arrl recording of 
responses from electrodes implanted in cats' brains, he found that 
certain chemicals inhibit synaptic transmission. Some of these such as 
mescaline and LSD-25 are associated with psychotic-like symptoms in man 
while others, like serotonin, occur naturally in the central nervous 
system. Marrazzi found that chlorpromazine partially counteracted the 
cerebral synaptic inhibition of a test dose of mescaline, even though 
chlorpromazine has no apparent effect on the synaptic transmission 
itself. 
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From this, Marrazzi (1957 a), inanother article, presented a 
homeostatic model of mental health in which there is postulated an 
appropriate chemical balance in the boqy . The tranquilizers are seen 
as counteracting the effects of excessive adrenalin, serotonin, or 
other chemicals in the nervous system. The neurophysiological approach, 
thus presented, offers a framework within Which to explain tranquilizer 
effect and action in humans. 
B. Clinical Psychiatric Research 
The greatest portion of research reported on chlorpromazine has 
been of a clinical psychiatric nature . Effects on behavior, methods of 
behavioral evaluation, and drug dosage determinations are issues 
examined in the literature, which have special pertinence to the present 
research . 
Taylor (1956), studying psychotic and neurotic in-patients, 
stressed duration and intensity of dos~ge . He felt that average daily 
dosage should be between 150 and 400 mg. per day, and that the regimen 
should be continued from one to four months. · With such treatment, 
improvement was reported in S6 percent of the cases . Conran (195S) 
agreed on the importance of dosage and related it to the severity of the 
disturbance. He stated that the more seriously disturbed the patient 
was behaviorally, the greater was the dosage needed. It was felt that 
a minimum total dose of 50,000 milligrams over a minimum period of 
nine months was indicated in an adequate clinical trial. 
Kinross-Wright (1955) advocated gradual dosage build-up to a 
"therapeutic level, 11 defined as 11 ••• when the patient begins to 
communicate, to become socially responsive and to show an improved 
quality of affect." (p. 53) Therapeutic dosage level for Kinross-
Wright ranged from 800 to 3600 mg . per day with a rean dosage of 2400 
mg . Under this regimen, he reported 76 percent of a 108 patient sample 
experienced complete or social rem is sian. 
On the other hand, Ayd (1958), using large doses, found that 
patients undergoing high dosage treatment exhibited symptoms which are 
typical of hypothalamic lesions. The patients were somnolent, exhib-
ited some catalepsy, had masklike facies and slowness of movement. He 
concluded that large doses of chlorprurnazine were no more effective 
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than the usual dosage of 200-300 mg. daily, except in the occasional 
patient. From this series of studies, it appears that dosage probably 
was a function of the severity of the psychiatric disturbance being 
treated and of the researcher. Behavioral changes associated with chlor-
promam.ne probably are observable within a wide range of dosages. 
Attempts .... have been made at objectively evaluating behavioral 
changes produced by chlorpromazine. Gilmore and Shatin (1959), in a 
double blind study, evaluated disturbed behavior and the perceptual 
distortions of hallucinations and delusions. The drugs used were chlor-
promazine, promazine, and a placebo. A psychiatrizt and ward nurses 
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were used as raters to evaluate ~he behavioral changes in the patients. 
Chlorpromazine was found to be better than either promazine or the 
placebo in ameliorating the observed symptoms. 
Freeman, Arnold and Cline (1956) used the Malamud-Sands rating scale 
to evaluate drug effects in two studies. In the first, they found that 
chlorpromazine produced changes primarily in ward behavior and also in 
increased socialization. They further found, as did Gilmore and Shatin, 
that PLacebo, too, produced improvement in patients. In a second study, 
Freeman and Cline (1958) matched two groups of lobotomized schizophrenic 
patients and administered chlorpromazine or placebo on a double blind 
basis. At a daily dosage of 800 mg., the scores on the rating scales 
for the two groups were differentiated. The chlorpromazine group showed 
a significant trend toward betterment in their scores. Responsivity, 
socialization, perception, and thought processes were improved signifi-
cantly. Such changes further suggested that chlorpromazine did function 
in the area of cerebral and sensory function, even jf the mechanisms were 
not yet clearly established. As Himwich (1960) noted in his conclusion: 
thus far in the field of psychopharmacology, practice 
has outstripped theory. Though we recognize that tranquilizers 
correct certain schizophrenic symptoms, there is little agreement 
on the mechanism by which improvements are achieved. Whether or 
not drugs affect cures is a problem for the future. But the 
practical value of the advance should not be underestimated. (p. 79) 
G. Behavioral Research 
Effects on behavioral functioning and processes have been investi-
gated in a controlled manner, with the ann of better understanding drug 
function. Blough (1957), in a test of visual discrimination on pigeons 
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found that LSD and chlorpromazine had opposite effects on discriminative 
accuracy. LSD improved visual discrimination in the operant condition-
ing task while chlorpromazine decreased the accuracy of responding. 
Both drugs decreased the response rate initially ani the chlorpromazine 
effects increased with the size 'of the dose. The fact that LSD improved 
visual discrimination while chlorpromazine impaired it, tends to 
support Marrazzi's (1957 b) findings af the antagonistic neurological 
effects of the two drugs. 
Berryman, Wagman and Keller (1960) used albino rats to evaluate 
chlorpromazine's effect on discriminat:ion of propr:ioceptive cues. They 
used a conditioning situat:ion wherein relevant exteroceptive cues were 
absent so that the rat only derived cues from his own behavior. A 
dosage of 0.2 mg. chlorpromazine per kg. of body weight was used. 
Noticeable deterioration of discrimination was noted, and the deterio-
ration increased over time. It was concluded that chlorpromazine impairs 
discrimination of proprioceptive cues. 
Witt (1961) reported on several oonditioning experinents in which 
the responding of experimental animals was affected. Brettschneider ~· 
al. (1959) demonstrated that conditioned avoidance responses were pro-
gressively impaired with increased chlorpromazine dosage. This suppress-
ion of the avoidance response, rope climbing, was thought tote a result 
of delayed responding rather than an inability to respond or a mispercep-
tion of the oonditioned stimulus. 
Ma.ffi (1959) found that rats, after avoidance training, would Jeave 
before the conditioned stimulus, a light, was flashed. He called this 
a "secondary conditioned response. 11 Administration of 1. 75 mg. chlor-
promazine per kg. weight resulted in a 50 percent block of this 
secondary conditioned response, but 11. 6 mg. chlorpromazine per kg. 
weight was needed to produce a similar suppression of 50 percent 
in the conditioned response. There seemed to be a hierarchy of 
responding, where the least reinforced and most complex response, 
calling for anticipation of a stimulus, disappeared most rapidly 
with the smallest drug dosage . 
Witt (1961) showed that web building responses of spiders were 
impeded by large chlorpromazine dosages but that the quality of the 
we~ building was not adversely affected . These last studies suggested 
that the overt responding was affected but that the capacity to 
respond was not markedly impaired . 
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fitt (1961) cited another study in which rats were placed under 
stress. As part of the manifestations of stress, an increase was 
noted in the fatty acids content in the blood . Chlorpromazine, given 
pre-stress, lowered the fatty acids in the blood, the decrement of 
fatty acids being related to the size of the dose and the time pre-
stress. It is stated that the rats seemed to feel the shocks but 
reacted less, both behaviorally and physiologically, after chlorproma-
zine . The subjective quality of intensity of the experienced shock 
post-chlorpromazine could not be measured. 
Finally, Killam and Killam (1958) reported the effect of chlorpro-
mazine on waking threshold as compared to reserpine and pentobarbital. 
The threshold was measured by implanting electrodes in the reticular 
formation, and applying stimulation through the electrodes. If the 
stimulation was above threshold, the subject would awake. Reserpine 
produced no change in waking threshold; 5 mg. chlorpromazine per kg. 
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weight produced a 20 percent rise, while pentobarbital more than 
doubled the threshold. Chlorpromazine seemed to cause a rise in waking 
threshold and a decrease in reticular transmission in this case. 
Behavioral research in humans has been done on both normal and 
clinical populations. Porteus (1957 a, b), and Porteus and Barclay 
(1959), in a series of studies, evaluated chlorpromazine results on 
the maze test scores of hospitalized patients. They found that chlor-
promazine produced impairment in maze performance which was comparable 
to results found in patients follcwing psychosurgery. It was proposed 
that the drug acted as a "chemical or pharmacological lobotomy • 11 
Porteus noted that, of the psychological functions affected, mental 
confusion and speech disorders were improved the least by chlorpromazine. 
He felt that these functions were most closely related to intellectual 
tasks and used this as evidence that 11 ••• the drug acts more on the 
basal ganglion or the cortico-thalamic arcs than on the oortex. 11 
(1957 b, p. 33) This conclusion seems un'Narranted, since maze perform-
ance depends on intricate visual-motor coordination and planning 
ability which appear to be related to cortical function and intellect. 
Porteus further stated that,as the drug administration continued for 
longer periods, the impairing drug effects increased, and the maze 
performance gap between the placebo and experimental groups widened. 
In any case, it appeared to Porteus that social and ward behavior were 
improved even though maze performance was adversely affected. 
Other workers have reported that effects of drugs vary with the 
personality of the subjects. Personality variableswou:W. be particu-
larly important in research designs using few subjects. Kornetsky and 
Humphries (1957), in evaluating responses of ten healthy vOlunteers, 
noted that subjects most affected by one drug were also effected by 
others. The psychological effects produced were independent of spec-
ific pharmacological activity of specific drugs but were somewhat 
dependent on the reaction tendencies of the subject. To evaluate 
personality, the authors used four scales of the ~linnesota Multiphasic 
Personality Inventor,y (MMPI) and reported: 
the more deviant a subject on the MMPI scale, the greater 
the drug effect • • • • the reactors are likely to be those 
people who are more depressed (the D scale) and/or likely to have 
more unreasonable fears of things, as well as over-react to 
environmental stimuli (the pt scale). (p. 327) 
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Di Mascio and Klerman (1960) reported findings similar to those of 
Kornetsky . They reported that, in a series of studies, they had found 
that personality played a role in drug effects. In their conclusion, 
they stated: 
that individuals whose personality was organized about active 
master,y of the environment (by athletic prowess, hostile outbursts 
or extra-punitive acts) found sedative drug actions ego threatening 
and therefore reacted with denial and negation of effects. In 
contrast, passive, intellectual, intrapunitive and anxious indiv-
iduals accepted more readily sedative drug actions and experi-
enced great reduction of anxiety and tension. (p. 362) 
From this, it would appear that the selection of subjects might 
well influence the drug effects demonstrated. 
Specific standard tasks have been used to evaluate drug effects. 
Kornetsky, Humphries, and Evarts (1957), using normals, evaluated the 
effects of several drugs including chlorpromazine (100-200 mg.) on the 
following seven standard tests: (l) speed of addition -- 3 digits; 
(2) speed of addition -- 9 digits; (3) modified digit symbol; (4) 
speed of copying numbers; (5) pursuit rotor; (6) tachiStrncopic 
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presentation of circle size; (7) tactual threshold . Tests were admin-
istered 75 minutes after the drug was ingested. The digit symbol test 
and pursuit rotor were significant~ impaired by 200 mg. of chlorpro-
mazine . The authors conclude: 
Chlorpromazine and secobarbital affected motor tasks but in 
general did not cause statistically significant impairment of 
performance on simple intellectual and perceptual tasks . (p. 323) 
Ison (1957) investigated the effects of chlorpromazine on intellect-
ual tasks , i.e. Wechsler tests, using two groups of retarded subjects, 
a chlorpromazine group and a placebo group . He founi that there was 
no change in either group in intelligence quotient . However, ther-e 
appeared to be increases in scores on Digit Symbol and Comprehension 
tests for both groups. The verbal performance in brain damaged subjects 
also tended to increase. 
Shatin, Rockmore and Funk (1956) used psychiatric patients for 
their research which, in other respects, was similar to that of Kornetsl<y 
et. al . cited above . Specific tests were used to evaluate the effects 
of SOO mg . of chlorpromazine per d.a;y and 3-3/4 grains of sodium amo-
barbital per day. The tests which were used were: (1) stylus tapping; 
(2) three hole tapping; (3) Digit Span forward and back; (4) Digit 
Symbol; (5) counting backward from twent,y to one; (6) strength of hand 
grip; (7) word fluency, i . e . a number of words written in twenty 
seconds; (S) ability to judge passage of twenty seconds; (9) MacQuarrB 
Tracing Test; (1) MacQuarrie Tapping Test; (11) MacQuarrie Dotting 
Test . 
The authors found that chlorpromazine did not lower performance 
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below a pre-medication comparison performance while amobarbital consis-
tently decreased function on the tasks • Chlorpromazine in s ome cases 
even yielded significantly improved results . The disparate results 
between this study and that of Kornetsky, Humphries, and Evarts (1957) 
could be explained by differences in choice of subjects . Kornetsky ~ 
al. used normals while these subjects were psychiatric patients . This, 
again, highlights the role of the individuals ubjects in determination 
of drug effects and the special care needed in evaluating research 
results . 
Kornetsky, Pettit, W,Ynne, and Evarts (1959) investigated the effects 
of drug administration on performance of tasks. These researchers used 
two drugs chlorpromazine and secobarbital; and two groups -- a 
schizophrenic group ani a normal group from a prior study. There were 
two conditions of drug administration, single dose and sustained dosage. 
Chlorpromazine dosage levels were 100 and .4)0 mg. twice per day. When 
administered as a single dose, the 100 mg . dose had no significant effect, 
but the 200 mg . dose impaired performance on digit symbols, pursuit rotor, 
tapping speed, end simple visual reaction time . With sustained drug 
administration, chlorpromazine caused no statistically significant impair-
ment in performance on any of the tests . The authors found no improve-
ment with sustained administration of the drug for either group and 
speculated that this might have been the result of their selection of 
only cooperatives ubjects . In conclusion, they stated that secobarbital 
impaired the performance of schizophrenics ani no:rms.ls to the srure 
extent, while chlorpromazine, in single doses, caused less impairnent in 
schizophrenic patients than in normals. 
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The decrease in effect under sustained drug administration noted 
above suggested a development of tolerance for chlorpromazine . Lehmann 
and Hanrahan (1954), in support of this observation, noted that an 
increase in dosage of chlorpromazine is necessary after a few days to 
maintain a constant level of sedation. They found that once a tolerance 
had been developed, patients did not get drowsy, that higher psychic 
functions were preserved, and that patients were capable of sustained 
attention, reflection and mancentration . 
Brodie (1958), in evaluating chlorpromazine effects on simple and 
disjunctive reaction time, took a step toward exploration of the effects 
of the drug on sensory processes . Disjunctive reaction time required a 
sensory discrimination to be made before responding motorically . Brodie 
predicted, based on a Kornetsky study, that sensory functioning would 
not be impaired at low chlorpromazine levels, but that at higher dosage 
levels disjunctive reaction time would increase . He found that the 
increasefrom pre-drug to post-drug mean reaction time was smaller for 
disjunctive reaction time than for simple reaction time at the lower drug 
dosage levels . However, at dosages of 100 to 150 mg . , "impairment of 
disjunctive reaction time was considerable . 11 
Lehmann and Csank (1957), using some perceptual and some motor tasks, 
attempted to differentiate action of six drugs, one of which was chlor-
promazine . The tasks were: critical flicker fusion frequency, after=image 
disappearance level, brightness constancy, tapping, reaction time, hand 
steadiness , digit span, digit symbol, and cancellation of digits . The 
subjects were healthy volunteers . Chlorpromazine significantly decreased 
after-image sensitivity, flicker fusion frequency , as well as tapping 
speed. Caffeine and dextro-amphetamine sulfate, both stimulants, 
improved performance in most tests While the depressant, secobarbital, 
impaired most functions tested. Critical flicker fusion frequency was 
one c£ the tests which the authors found best sui ted for differential 
screening of the phrenotrop ic drugs. 
D. Summary 
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The foregoing review indicates the multiplicity of areas that the 
drug, chlorpromazine, affects. It also indicates the limited knowledge 
and contradictory evidence related to chlorpromazine. The area of 
drug effects on sensory processes is one of the least clearly delineated. 
Effects have been more clearly demonstrated in the motoric sphere, and 
yet, the question of chlorpromazine action at the level of perception 
of the stimulus persists even here. At the more directly sensory 
perceptual level, it has been demonstrated that chlorpromazine 
diminishes the accuracy of visual discrimination, and inhibits the 
discrimination of proprioceptive cues in animals • It also raises the 
waking threshold in cats and reduces physiological responses to stress . 
In humans, chlorpromazine impairs maze function and impedes discrimina-
tion in a disjunctive reaction time task. Yet, it improves perception 
ins chizophrenics and tends to r educe perceptual distortions in this 
group . Effects also have been reported on visual after-image sensi-
tivity ani CFF. It is l ikely that to produce such a broad range of 
observable phenomena, the actions of the drug must b e very complex and 
widespread. 
A model to explain chlorpromazine acticn was proposed in the litera-
ture by Marrazzi (1957 a, b). In this theoretical formulation, it is 
suggested that the drug acts at the neuronal synapses to modify 
17 
biochemical processes. Marrazzi 's (1957 a, b) model tends to explain 
the multiple action of this drug, and t:ermits us to infer that any 
phenomenon which is mediated by neuronal structures would be affected 
by chlorpromazine. The evidence derived from the literature precludes 
the possibility of directional prediction, however, because opposite 
effects have been reported by different authors. On the other hand, 
the visual perceptual process has been one of those most widely 
investigated with chlorpromazine and this drug is one of the most 
widely used in the tranquilizer group. It -wouJd seem that further 
investigation into the interrelationship of t:IE drug and 1he visual 
process could be productive, even if only a non-directional prediction 
may be inferred from the literature . 
CHAPTER III 
INTERSENSORY EFFECTS 
There has been a recent resurgence of interest in the issue of 
how stimulation of one sense modality produces chaqses in the 
functioning of another sensor,r system. Recent workers in the area 
have attempted to define and specify the conditions that contribute 
to the observed intersensory effects of facilitation with low level 
stimulus intensity and inhibition with mre intense stimulation. 
The literature in the past has been confusing and at tines 
contradictory. Urbantschitsch (1883) was among the first to explore 
the intersensor.r area. In pioneering work, he reported that auditory 
stimulation with a tuning fork increased visual sensitivity, that 
color perception was influenced by the pitch of an accessory tone, 
and that the ticking of a watch couJrl be heard more clearly with the 
eyes open than with them closed. 
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Kravkov (1934), investigating visual function, found that acuity 
in one eye was changed by diffuse general stimulation oft he other eye. 
He then used auditory stimulation and showed that, with sound, the 
ability to discriminate white figures on a black ground was decreased. 
Hartman (1933 a, b) found facilitation in the perception of both 
black figures on a white ground andwlite figures on a black ground. He 
showed that visual acuity could be increased by multiple means, and 
used as accessory stimuli auditory, olfactory, and cutaneous stimu= 
lation . Hartman felt that any auxiliary stimulus increased visual 
acuity independent of the nature of the test objects . He attempted 
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to explain these intersensor,r effects by a facilitative or tonic effect 
which spreads or diffuses across systems . 
Other investigators showed inhibitory effects of accessory stimu-
lation. Heymans (1904) demonstrated that electric shock, applied to 
the hand, negatively affected the ability of a subject to hear a 
ticking watch . With no shock, the watch was heard for almost the 
entire trial period . As shock was introduced and increased in inten-
sity, the ability of the subjects to hear the watch decreased so that 
at maximum shock intensity, ticking was heard only 69 seconds out of a 
possible five minutes. 
Other studies have shown that various primary stimuli are affected 
differently by the same auxiliary stimulus . Allen and Schwartz (1940) 
demonstrated that while perception of red light was inhibited by sound, 
taste, and smell stimulation, the perception of green light was 
facilitated using the same stimuli. They also showed that a soft tone 
increased CFF while a loud tone decreased it . 
Kravkov (1954) produced results similar to Allen and Schwartz . 
Kravkov showed that perception of green light increased sensitivity 
and perception of orange light decreased sensitivity as accessory audi-
tory stimulation was increased . He used this finding to contradict the 
generalization of an apparent "rule of inversion" put forth by himself and 
some other Russian workers . They observed that: 
Increase in strength of the accessory stimulus leads so frequently 
to effects that are the reverse of those induced by weaker inten-
sities that one can almost speak of a 'rule of inversion ' •••• 
For example, sounds of weak intensity heighten the electrical 
sensitivity oft he eye, while those of increasing intensity are 
accompanied by a gradual decline . (pp . 538- 539) 
A theory to explain the observed facilitation and inhibition of 
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sensory function was initiated by Davis (1953) and elaborated by Trehub 
(1954). Davis (1953) postulated a structure called the "mutually 
recruitable neuron" (MRN). This structure can be recruited to more 
than one sensory system ani is thought of as providing a mechanism for 
shifting excitation between competing sensory systems. 
rehub (1954) postulated that as intensity of accessory stimulation 
increased, a facilitation field of increasing magnitude is generated. 
He assumed that there is a finite number of MRN elements. Facilitation 
by accessory stimulation changes to inhibition when the facilitation 
field contributes more heteromodal elements to the secondary system. 
This is explained in the theory by assuming that tre gain of MRN increases 
as a logarithmic function of increasing accessory stimulation while the 
loss of MRN occurs as an ogival function of increasing accessory stimu-
lation. The proposed ogival function is based upon the assumption that 
thresholds in pathways joining sensory ani MRN elements are normally 
distributed. The logarithmic function is based on the assumption that 
sensory receptors respond logarithmically to the intensity of the stimuli 
impinging upon them. ,The resultant of these tw:> curves is presenterl in 
Figure l. As can be seen, the sensitivity of the primary modality is 
facilitated with weak accessory stimuli. As the secorrlary stimulation 
gets stronger, however, inhibit jon is produced in the primary modality, 
so that primary sensitivity is decreased below the point of no 
accessory stimulation. 
Wiesenfeld (1955) generalized ani elaborated on the former work 
and demonstrated the occurrence of the heteromodal effect. He postu-
lated two kinds of sensory elements, each with a finite number. One 
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kind can function in only one sphere while the other can be affected by 
any sensory stimulus. This second element is the :MRN. It may function 
in any modality and mey- be subliminally excited by sensory stimulation. 
Once it is included in a sensory system, it continues to contribute to 
that system so long as the intensity of stimulation does not decrease. 
While the l{RN can function in more than one sensory s.ystem, it can 
function in only one system at a given time. Change in the number of 
MRN elements contributing to a systan when a second stimulus is intro-
duced will define the change in t~ total number of elanents contribu-
ting to that system. In his study, Wiesenfe]d used vision as the prfuary 
and audition as the secondary sense modality. He danonstrated that 
with soft tones sensitivity was increased. As the tones became louder, 
visual sensitivity was impaired and sensory inhibition occured. Thus, 
the :MRN model has evolved and gener-ated a l::ody of anpirical data from 
which predictions may be made. 
Levine (1958), using the MRN model, varied not only the accessory 
stimulus but also the i ntensity of the primary light source in a CFF 
apparatus. He reasoned that increasing the primary stimulation 
should increase the specific elanents contriruting to the primary 
modality, and also the number of MRN available for recruitment to eit..l'lar 
sense modality. He demonstrated that the i ntensity of the primary 
visual stimulus was directly related to the magnitude of the hetero-
modal effect. 
A repeated observation, noted in recent intersensory s tudies, is 
an inversion oft he inhibitory effect after the inhibitory phase of the 
curve has been reached. Further examination and elaboration of the 
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theory to account for this phenomenon is necessary . Munro (1962), in 
investigating this problem, used not only vision and audition but 
included a third sense modality, the kinesthetic . This was achieved 
by attaching weights to the subject ' s wrist. Thus, two accessory 
stimuli could be summated . This proce~ure was based on the assumption 
that the puzzling inversion is a periodic phenomenon that reappears 
if the theoretical curve is extended far enough . Munro found that 
the inversion did recur under dual accessory stimulation. As a result, 
it now appears that the data fit with the addition of a sinusoidal curve 
superimposed on the logarithmic and ogival curves . 
A. Critical Flicker Fusion Freguency 
Critical flicker fusion frequency, or CFF, has proven a useful 
measure of visual sensitivity. This technique was used by Wiesenfeld, 
Levine, and Munro in the studies reported a~ove . It has been selected 
for use in the present study. CFF has demonstrated its sensitivity 
to various externally introduced determinants . Landis (1954) has 
reported that CFF is sensitive to oxygen lack , presence of carbon 
monoxide, carbon dioxide, and many drugs . Landis, Dillon, and Leopold 
(1956) demonstrated changes in flicker fusion threshold following 
electro-convulsive therapy . Berg (1949) used CFF with a drug, evipan, 
to formulate a normative scale for evaluating brain injury. Krasno 
and Ivy (1950) used CFF to evaluate the differential effect of nitro-
glycerine on normal and cardiac patients . Finally, Roback, Krasno , 
and Ivy (1952) measured drug effect s with flicker thresholds . The 
authors stated: 
It would appear that the flicker fusion technique can detect 
a significant depression oft re central nervous system 
resulting from the administration of 1he anti - histaminics 
thenylphyramine , furdylamine, ani benadryl. It becomes 
evident that depression of ihe nervous system due to anti-
histaminics can exist in the absence of subjective drowsiness 
• • • • The FFT (flicker fusion threshold) would appear to 
be a sensitive and reliable methcxi for objectively detecting 
the less obvious depressirg and stimulating effects of anti-
histaminics, barbiturates, and sympathomimetic drugs on the 
nervous system. (pp . 572 & 574) 
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A problem in using CFF as cited by Landis (1954) is the very wide 
interindividual variability . He suggested that subjects ' results 
should be compared to the:ir own basic threshold. The present research 
was designed with this precaution :in mind . Each subject served as his 
own control . 
B. Summary ani Research Predictions 
This study was, in part, a replication of recent intersensory 
research. The intersensor,r technique was also used to investigate the 
effect of chlorpromazine on sensory processes . The MRN model was 
chosen because it provided a body of empirical data from which predic-
tions could be made . For example, if threshold sensitivity depends 
upon sensory neurones, then a change in threshold sensitivity with the 
administration of chlorpromazine would indicate the effect of the drug 
on these structures. Changes in inter s ensor,y effect, however, would 
indicate drug action on the postulated MRN, since the theory states 
that the heteromodal effect is related to the gain and loss of MRN ~. 
It is therefore hypothesized that the bipolar effect on visual 
sensitivity which is associated with accessory auditory stimulation 
will be modified by chlorpromazine . In order to test this hypothesis, 
it is assumed that the curvilinear intersensory function will appear 
under the placebo condition. This would be a replication of prior 
studies. It is necessary to demonstrate this relationship before the 
primary issue, stated above, can be dealt with. 
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The plan of research also permits an explorator,y assessment of the 
effect of chlorpromazine on visual sensitivity in the absence of 
accessory stimulation. 
CHAPTER IV 
METHOD AND PROCEDURE 
In order to test the hypothesis proposed in the last chapter, it 
was necessary to design the research so that visual sensitivity might 
be examined under conditions of auditory stimulation with and without 
chlorpromazine . The plan was to evaluate visual performance by using 
a continuous record of CFF thresholds obtained througha modified 
method of limits . The secondary stimulus used to provide the inter-
sensory effects was an auditory tone . Both CFF measurement and audi-
tory stimulation were carried out in the context of a double blind 
drug design, with the entire research procedure being conducted under 
placebo and chlorpromazine conditions . 
A. Methodological Considerations 
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It was decided that the research data would be collected by making 
repeated observations in a single subject . This was done to reduce 
inter-subject variation, to evaluate reliability of performance, to 
evaluate effects across time, and to study indepth the subject's 
reactions . Each subject served as his own control. This was done to 
minimize subject to subject variation in CFF, which often is considerable . 
Each subject was examined under the drug and placebo condition, and so 
each subject was a complete experiment . 
It was also decided that the research would be done with sustained 
medication . It was felt that this method would more closely approximate 
the way that chlorpromazine is ordinarily used . The results would 
provide an opportunity to assess the varying effects of the drug over 
time and to study build up and habituation phenomena, if they appeared . 
The sustained medication design also permitted establishment of base 
lines of performance for each subject under sustained drug and placebo 
conditions. A prior pilot study in which drug and no-drug days were 
alternated yielded ambiguous findings . The inconclusive results in 
the alternate day design were consistent with medical uncertainty about 
how long chlorpromazine is retained in the human body, and supported 
the decision to use sustained medication as the mode of drug admini-
stration in the present research . 
B. Measurement of CFF 
The measurement of visual sensitivity was critical flicker fusion 
frequency . This was obtained by averaging the flicker thresholds and 
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the fusion thresholds . Increased ability to discriminate higher frequencies 
of flicker and fusion indicated greater visual sensitivity. The CFF 
thresholds were generated by the subjects who were asked to depress a 
hand switch while viewing the flicker ing light patch . They were told to 
hold the switch in the depressed position until the light appeared 
steady, at which point the switch was to be released. When the flicker 
in the light patch reappeared, the switch was to be depressed again . 
The subjects were instructed to continue to depress and release the hand 
switch until they were told to stop . 
The light source for producing the flicker was a glow modulation 
tube (S~vania Type Rll3l C). This tube was powered by an electronic 
pulse generator which produced equal periods of light and dark. The 
range of pulse frequencies which the generator could deliver to the glow 
tube was from seventeen to ninety cycles per second. Changes in the 
pulse frequency could be produced by turning a shaft which attached to 
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the variable conienser plates of tre generator. 
The light fran the glow modulator tube was directed at a ground 
glass screen which was located at the back of the viewing box. The 
subjects viewed the flickering light from a distance of atout twenty-
four inches by placing the.ir faces against a head-rest which led to a 
slit in the front wall of the viewing bax: • Trn head-rest fixed the 
position of the subject's head and directed his gaze at the circular 
light patch which was about one inch in diameter and which, at the stated 
distance, subtended a visual angle of about two degrees. 
The flicker and recording apparatus was actuated by a hand switch 
which controlled a reversible IIOtor. This motor was coupled to a gear 
on the shaft of the pulse generator which, in turn, attache:i to the 
variable condenser plates and changed the pulse frequencies delivered 
to the glow tube. When the hand switch was depressed, the motor turned 
in a direction which produced an increase in flicker frequency. When 
the switch was released, the motor reversed direction ani, b,y so dalng, 
decreased the flicker frequE:Ilcy. 
The reversible motor was connected by a chain and system of pulleys 
to a glass pen which recorded the flicker and fusion points on EID 
recording paper. The flicker and fusion points appeared as peaks and 
troughs ani had to be convertErl to values equivalent to those of the 
pulse generator. For this purpose, a scale was constructed to match 
the pulse generator output. The units oft he scale and the data are 
reported in cycles per second. 
C. Auditory Stimulation 
The accessor,r auditory stimulation consisted of seven intensities 
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of a 1550 cycles per secon:i tone . Tre intensity ranged from 77 to 96 
decibels . The specific tonal intensities may be seen in Appendll: C. 
The t ones were generated by an audio oscillator and were delivered to 
the subject by means of ear phones . The tones were presented in random 
fashion on each day ani each CFF performance in t m presence of tone 
was paired with a preceding CFF performance without tone . Between the 
no-tone and tone period was a rest of one minute. The tone was gradu-
ally maximized to the selected intensity over a b:>ut a five secord 
period . The collection of thresholds was started only after the tone 
had been set to the desired intensity . It was expected tha. t the mean 
CFF threshold differences, tone minus no-tone, across the range of t~ 
would approximate the curve in Figure 1 . 
D. Drug Stimulation 
Chlorpromazine, in 100 mg . tablets, was administered daily over a 
two week pericxi to each subject . To get a comparative base line, the 
subject received identical appearing placebo tablets in a second two 
week period . There was also a two week rest period between the tw 
blocks of time, during which no medicaticn was given . In an attempt 
to control possible sequence effects, tm order of administration of 
pJacebo and chlorpromazine was reversed with the two subjects studied . 
Following a double blind procedure, neither the experimenter nor the 
subjects knew which was getting the drug first and which the placebo. 
The experimenter, however, did know that all the tablets in each period 
would be the same . The drug dosage of 100 mg . per day was selected on 
medical advice as likely to produce significant effects with normals 
without incapacitating drowsiness . 
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E. Subjects 
Two normal subjects were used in this experiment . Both were in-
mates at a Massachusetts Correctional Institution . Theywere screened 
by the medical department and both were in excellent physical cond.it:k:n 
and had no histor.y of emotional disturbance, drug addiction or liver 
reaction. 
Subject l was a 26 year old man with uncorrected visual acuity 
15/20 (by the Snellen chart) in each eye and superior hearing as evalu-
ated by audiogram. He was 6 1 2" tall and weighed 167 pounds . His pre-
test blood pressure was 122/70. Subject l was anployed in the institu-
tion hospital as an inmate nurse . 
Subject 2 was a 37 year old man with uncorrected visual acuity 
20/20 (by the Snellen chart) in each eye and normal hearing as evalu= 
ated by audiogram. He was six feet tall an:i wei~ed 180 pounds. His 
pre-test blood pressure was 124/80 . He was employed in the maintenance 
crew within the institution, and his primary job was that of welder . 
Both rubjects were followed continuously by the institution 
physician because of the possibili~ of adverse side effects . None 
occurred, although Subject 1 had a gastrointestiml upset on the ninth 
day of the placebo series . He was given paregoric. To counter this, 
his testing was interrupted. He was given a t"-0 week rest and then was 
given a pill a day for nine days at which time testing was resumed. 
F. Experimental Procedure 
Each subject was given an initial familiarizat:ion and training 
course . In it, the subjects were acquainted with the apparatus and its 
general functioning. They were given an opportunity to see it in 
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operation and to explore ani question. 
The subjects were thoroughly trained in tre actual performance of 
the task which they were to execute. The extensive training period was 
given in order to reduce intra-subject variation and thus to assure CFF 
threshold reliability. Also, Trehub (19541 who made use of GSR as an 
accessory stimulus, cautioned that a state of anxiety could be a 
secondary stimulus and confound e.xperinental results. It was felt that 
the lengthy familiarization ani training would tend to reduce anxiety. 
~ubject 1 received a bout six weeks of daily training while Subject 2 
was a subject for the pilot study and so had considerably more training, 
perhaps fifteen weeks in all. At the start of the experiment, ooth were 
able to produce consistent records. 
A typical test day would begin with ingestion of the drug in the 
hospital. The subject would go al::out his business for the next 45 
minutes, at which time he would report to the test area. Here he would 
don dark adaptation goggles and a check would be made of his hearing, 
using a tone of 1500 c.p.s. After he was dark adapted, a period of 
about twenty minutes, the collection of the data was begun. Thirty 
seconds of thresholds were obtained in the absence of auditor.r stimu-
lation, followed by a one minute rest. One of the seven tonal intensities 
employed then was introduced ani again thirty seconds of thresholds were 
obtained. The subject then rested two minutes. The procedure was then 
repeated for each of the six other tones, each tone performance being 
preceded by a no-tone performance with which it was paired. In this ~' 
seven pairs of threshold sets were collected each day. The time needed 
to collect the daily data was about half an hour. 
CHAPI'ER V 
RESULTS 
A. Operational HypothesJs 
The hypothesis to be tested can be stated in operational terms as 
follows: The differences between mean CFF thresholds for the tone and 
the no-tone condition depend upon both tonal intensity and presence or 
absence of the drug, chlorpromazine . 
This operational hypothesis was supported by the data obtained fran 
Subject l but was not supported b.r the data obtained from Subject 2. 
However, an overall difference between the drug and placebo conditions 
was observed inboth sets of data. 
B. Experimental Results, Subject 1 
The performance of Subject l is summarized in Figure 2 which shows 
the mean threshold differences calibrated in cycles per second. The 
dotted lines represent the mean CFF threshold d:ifferences between tone 
and no-tone fort he seven tonal intensities, during the placebo period . 
The solid line represents the comparable data from the chlorpromazine 
:.1·eries. It was noted that the low intensity tones were associated with 
facilitation in both 1he placebo and drug condition. As tonal intensity 
increased, inhibition of visuaL function was noted in both conditions . 
However, increased facilitation ani increased inh:ibition of visual 
function was noted during the d1lorpromazine period. Fig1.lr' es 3 and 4 
graphically represent the tone and no-tone threshold means for the 
placebo and drug conditions . The tone ard no-tone threshold means 
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Figure 2 . Mean CFF threshold differences, tone minus no-tone , 
Subject 1. 
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Figure 3. Mean CFF thresholds, with placebo, Subject 1. 
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Figure 4. Mean CFF thresholds, with chlorpromazine , Subject 1 . 
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and the difference scores derived from the means are 33hown in tabular 
form in Table 1 . In both conditions, a tendenc,y toward reversal of 
the inhibitory effect was noted. This occured at tone 5. 
The data were analyzed as a four way classification analysis of 
variance carried out without replication. These analyses are shown 
in Appendix A. Since the basic hypothesis concerning chlorpromazine 
is non-directional, the data were evaluated with a two tail test of 
significance. 
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The relationship of facilitat:ion ani inhibi. tion to tonal intensity 
was predicted from prior research . It was expected that CFF would 
first increase ani then decrease as the intensity of the tone increasOO. 
Testing this prediction called for replication of studies by Wiesenfeld 
(1955) and by Levine (1958) and demonstrated the existence of the 
intersensory effect. It was implied in the interaction between the 
tone conditions and tonal intensities or levels (TC x TL). The hypoth-
esis of no interaction was tested and for 6 and 54 degrees of freedom 
yielded an F ratio of 13 . 73 and a P of less than .01. The hypothesis 
of no interaction was rejected and replication of the prior research 
was established. 
The operational hypothesis states that the differences between mean 
CFF thresholds for the tone and the no-tone condition depend upon both 
tonal intensityand presence or absence of the drug chlorpromazine. This 
prediction was confirmed by the data for Subject 1 . It was implied by 
the second order interaction among the drug conditions, tone coniit:ions, 
and tone levels (DC x TC x TL). The hypothesis of no interaction was 
tested in the overall analysis of variance and yielded an F ratio of 
TONE 
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3 
4 
5 
6 
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TONE 
1 
2 
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TABU!: 1 
MEAN CFF* THRESHOLDS IN RELATION TO 
TONAL INTENSITY, SUBJECT 1 
PLACEBO CONDITION 
NO-TONE MEAN TONE MEAN 
40.72 42.16 
40.06 41.14 
41.32 41.89 
41.42 41.11 
40 . 28 40.68 
40.88 40.54 
41.46 40 . 86 
DRUG CONDITION 
NO-TONE MEAN TONE MEAN 
39.90 42.16 
39.07 40.58 
39.50 40.09 
39.64 37.88 
40.27 38. 58 
39.70 37.74 
40.29 37. 76 
*CFF UNITS EXPRESSED IN CYCLES PER SECONDS 
FOR EACH MEAN N=10 
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DIFFERENCE 
+1.45 
+1.08 
-+0.57 
-0.31 
+0.40 
-0.35 
-0.60 
DIFFERENCE 
+2.25 
+1.51 
+0.59 
-1.77 
-1.70 
-1.96 
-2.53 
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2 . 84 which was significant at the . 05 level. The hypothesis of no inter-
action was rejected. 
As can be seen in Figure 2, the heteromodal effect was demonstrated 
in both the drug ani placebo conditions . However, the deviation of the 
trend lines is in the direction of greater facilitation and inhibition 
in the chlorpromazine condit:ion. This implies that both chlorpromazine 
and tonal intensities are associated with the intersensor.y effect . 
Further analyses of variance, reported in Appendix A, were carried 
out to attempt to partial out the effects of the presence or absence 
of chlorpromazine on differences between tore and no-tone CFF, on the 
seven tonal intensities and on the intersensor.y effects . To do this, 
two three-way classification ana]y ses were done, one for the placebo data 
and one for the drug data. Both analyses yielded significant differ-
ences across the seven tonal intensities (TL) ani for the interaction 
between tone G.onditions and tonal intensities (TC x TL). These 
interactions imply that the heteromodal effect occured under both placebo 
and drug conditions. Further, only the drug condition produced signif-
icant diff erences between 1he tone and no- tone con:ii tions (TC) . 
On evaluating drug and placebo effects, it was noted that greater 
facilitation at low tones and greater inhibition at high tones occurred 
under the drug condition tmn under the placebo condition. These data 
are presented in Figure 2 and Table 1 . It was noted, further, that 
there appeared to be a tendency toward greater mean CFF threshold differ-
ences over time. Accordingly, the first five dB\Ys were compared to the 
last five days for the drug and placebo conditions. These data are 
presented graphically in Figures 5 and 6 and intabular fonn in Table 2 . 
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Figure 5. Placebo mean CFF threshold differences , tone minus 
no-tone, first and last 5 days , Subject l . 
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Figure 6. Drug mean CFF threshold differences, tone minus no-
tone, first and last 5 days, Subject l . 
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TABLE 2 
MEAN CFF* THRESHOlDS COMPARING THE FIRST 5 DAYS WITH 
THE LAST 5 DAYS FOR TONAL INTENSITIES, SUBJECT 1 
PLACEBO CONDITION 
First 5 Days Last 5 Days 
NO-TONE TONE DIFFER- NO-TONE TONE DIFFERENrclE 
ENCE 
41.82 41 . 88 +0 .06 39 .61 42 .45 +2 . 84 
39 .66 41.03 +1.37 40 .47 41 .25 +0 . 78 
41 .33 42 .46 +1 .13 41.31 41.32 +0 .01 
41.51 40 .93 -0.58 41.33 41 . 29 -0 .04 
39 . 74 40 .22 +0 .48 40 .82 41.14 +0.32 
41.25 40.70 -0.55 40. 52 40 .37 -0.15 
40 .99 40 .48 -0.51 41.93 41.24 -0 .69 
DRUG CONDITION 
First 2 Da;y:s Last 2 Dazs 
NO-TONE TONE DIFFER- NO-TONE TONE DIFFERENCE 
ENCE 
39.76 40.87 +1.11 40 .05 43.44 +3.39 
38.98 39 .94 +0 .96 39 .16 41.23 +2.07 
39.36 39.24 -0.12 39. 63 40.94 +1.31 
38.63 37.99 -0 .64 40 .66 37. 76 -2.90 
40 .04 38.66 -1.38 40. 50 38.49 -2 .01 
39 .68 38.62 -1.06 39 .71 36 .86 -2.85 
40 .36 38.61 -1.75 40.23 36 .91 -3 .32 
*CFF UNITS EXPRESSED IN CYCLES PER SECOND 
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On inspection, the drug data showed greater facilitation and inhibition 
of CFF during the last five days than had been irrl icated during t re 
first five . The placebo data demonstrated no apparent difference 
between the first and last five day period. This suggested the possi-
bility of a build up of drug effect over time. 
C. Experimental Results, Subj ect 2 
The performance of Subject 2 is summarized in Table 3 and presented 
graphically in Figure 7. The dotted line in Figure 7 represents the 
placebo series ani presents the mean CFF threshold differences between 
the tone and no-tone conditions . The solid line denotes the comparable 
data for the chlorpromazine series . It was observed that tones of low 
intensity were not associated with the expected facilitation in the 
placebo condition. Neither was inhibition noted with tones of greater 
intensity in this series . The d:ug condition result appeared to be in 
the general direction of facilitation at the lower tonal intensities, 
and there was a suggestion of beginning inhibition at the loudest tone. 
Figures 8 and 9 present the tone and no-tone means for the placebo and 
drug conditions . These data, too, are given in tabular form in Table 3. 
The experimental eypotheses were tested in the four way classifica-
tion analysis of variance presented in Appendix A. 
It was predicted, based on prior research, that facilitation ani 
inhibition of CFF are ~a function of tonal intensity . It was expected 
that CFF would first increase and then decrease as the intensity of 
the accessory stimulation increased. This prediction was implied in the 
interaction between the tone conditions and tonal intensities (TC x TL) . 
The hypothesis of no interaction was tested and for 6 and 54 degrees of 
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Figure 7. Mean CFF threshold differences, tone minus no-ton~ 
Subject 2 . 
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Figure S. Mean CFF threshold~with placebo, Subject 2 . 
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Figure 9. Mean CFF thresholds, with chlorpromazine, Subject 2 . 
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TABLE 3 
MEAN CFF* THRESHOIDS IN RELATION TO 
TONAL INTENSITY, SUBJECT 2 
PLACEBO CONDITION 
TONE NO-TONE MEAN TONE MEAN DIFFERENCE 
1 42.29 42.61 +0.32 
2 42.69 42.54 -0.15 
3 42.75 42.75 o.oo 
4 43.ll 42.78 -0.33 
5 43.27 43.53 +0.26 
6 43.48 42.89 -0.60 
7 42.53 42.91 +0.38 
DRUG CONDIT ION 
TONE NO-TONE MEAN TONE MEAN DIFFERENCE 
1 44.16 44.60 +0.44 
2 43.58 44.18 +0.61 
3 43.73 44.20 +0.47 
4 44.36 44.41 +0.04 
5 43.92 43.94 +0.02 
6 44.24 44.35 +O.ll 
7 44.07 43.96 -O.ll 
*CFF UNITS :EXPRESSED IN CYCLES PER SECOND 
FOR EACH MEAN N=10 
freedom yielded an F ratio of less than 1. The hypothesis of no 
interaction could not be rejected. This finding indicated that Subject 
2 failed to demonstrate the heteromodal effect, in contradiction of 
expectations. 
The operational hypothesis states that the differences between 
mean CFF thresholds for the tone and the no-tone condition depend 
upon both tonal intensity and preserc e or absence oft l:e drug chlorpro-
mazine . This hypothesis was tested in the overall analysis of variance, 
where it is implied in the interaction among drug c on:ii tions, tone 
conditions, and tonal intensities (DC x TC x TL). The hypothesis of 
no interaction yielded an F ratio of less than 1, an:i trerefore oould 
not be rejected . 
As seen in Figure 7, tl:e heteromodal effect was not demonstrated 
in the placebo condition, while the drug curve resembled the expected 
form. The statistical analysis did not support the observation. 
Therefore, chlorpromazine and toml intensity cannot be said to affect 
the intersensory effects. 
The null hypothesis of no difference between the chlorpromzine 
condition and the placebo con:iition was then tested. This is implied 
in the DC variable of the analysis of variance. The null hypothesis 
was tested and for 1 and 54 degrees of freedom yielded an F ratio of 
99 . 59 and a P of less than .01. The null hypothesis was rejected . This 
implied that the drug data were s:ignificantly dliferent from the placebo 
data. 
47 
Two further three way classification analyses of variance were done 
sot hat placebo and drug effects might be evaluated . The null hypothesis 
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of no difference between the tone and no-tone CFF means (TC) was tested. 
In both the drug ani placebo conditions, the null hypothesis could not 
be rejected. 
The hypothesis of no difference among the seven tonal intensities 
(TL) was t ested. In the placebo condition, for 6 ani 54 degrees of 
freedom, an F ratio of 2.32 and a P of less than .05 was obtained. 
The null hypothesis was rejected. In the drug condition, the hypothesis 
of no difference among the seven tonal intensities could not be rejected. 
The heteromodal effect was implied by the interaction between the 
tone conditions and tone levels (TC x TL) in both the drug and placebo 
analyses. The hypothesis of no interaction was tested with the drug 
data and with the placebo data. In both cases, an F ratio of less than 
1 was yielded a rii neither hypothesis of no interaction could be rejected. 
A re-examination of Figure 7 in tre context of the statistical 
analysis indicated that while the facilitation and inhibit ion noted in 
the drug condition were in the direction predicted and observed in 
Subject 1, the differences obtained were too small to be statistic ally 
significant. 
Finally, Figures 10 and ll represent the mean CFF thresrold differ-
ences between the tone and no-tone conditions for the first and last 
five days in each series. This information with the appropriate means 
also is listed in tabular fo..Illlt in Table 4. These data failed to dem.o n-
strate changes in mean CFF threshold differences between the first and 
last five days in either the drug or placebo conditions. Further, there 
did not appear to be any significant heteromodal effect in either con-
dition. 
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Figure 10, Placebo mean CFF threshold differences, tone minus 
no-tone, first and last 5 days , Subject 2 . 
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Figure 11 . Drug mean CFF threshold differences, tone minus 
no-tone, first and last 5 days , Subject 2 . 
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TABLE 4 
MEAN CFF* THRESHOLDS COMPARING THE FIRST 5 DAYS WITH 
THE LAST 5 DAYS FOR TONAL INTENSITIES, SLBJECT 2 
PLACEBO CONDITION 
First 2 Da;y:s Last 2 Da;iS 
TONES NO-TONE TONE DIFFER- NO-TONE TONE DIFFERENCE 
ENCE 
1 42.30 42.60 +0.30 42.28 42.62 +0.34 
2 42.77 42.55 -0.22 42.62 42.54 -0.08 
3 42.32 42.76 +0.44 43.18 42.74 -0.44 
4 43.11 42.94 -0.17 43.12 42.63 -0.49 
5 42.87 43.26 -tD.39 43.67 43.80 +0.13 
6 43.07 43.51 +0.44 43.90 42.27 -1.63 
7 42.20 42.80 +0.60 42.86 43.01 +0.15 
DRUG CONDITION 
First 5 Da;is Last 2 Da;iS 
TONES NO-TONE TONE DIFFER- NO-TONE TONE DIFFERENCE 
ENCE 
1 43.18 44.15 +0.97 45.14 45.06 -0.08 
2 42.59 43.69 +1.10 44.57 44.68 +0.11 
3 43.76 43.67 -0.09 43.70 44.73 +1.03 
4 44.05 44.10 +0.05 44.67 44.71 +0.04 
5 44-13 43-42 -0.71 43.70 44.45 +0.75 
6 43.79 44.96 +1.17 44.69 43.75 -0.94 
7 44.22 43.65 -0.57 43.92 44.26 +0.34 
*CFF UNITS EXPRESSED IN CYCLES PER SECOND 
D. Chlorpromazine Effect on Mean CFF Threshold 
Figure 12 presents the daily no-tone mean of all CFF thresholds 
for both subjects during the pJa.cebo and drug ronditions . The lower 
line represents the performance of Subject 1 while the upper presents 
the data generated by Subject 2 . This figure shows the actual daily 
sequence of mean thresholds. As can be seen, Subject 1 received the 
drug during the f jr st period and the placebo during the secorrl, while 
Subject 2 reversed this order and received placebo initially. 
It was noted that there was a continuously rising no- tone mean 
CFF for both subjects throughout the experiment . For Subject 1 , the 
CFF was lower under drug while Subject 2 showed lower placebo CFF . 
The difference betwe en the drug and placebo CFF mean thresholds were 
subjected to a t - test which is tabulated in Appendix B. Both 
subjects 1 results yielded P' values of less than . 01 . 'the null hypoth-
esis of no difference between the placebo and drug no-tone mean 
thresholds for each subject was therefore rejected . Since Subject 1 
was given chlorpromazine first and Subject 2 was given placebo during 
his first series, it appeared that the djf ferences mted might best be 
explained as a practice effect . 
It also was observed tmt Subject 2 showed consistently higher 
visual sensitivity, this despite the fact that Subject 1 had superior 
visual acuity . Subject 2, however, had been the subject in the prior 
pilot study . His llbettertt performance gave strength to the practice 
effect explanation for CFF mean threshold shift over time . Further 
support was also given by audiometric data Which showed no hearing 
threshold changes over the twenty day test period in either subject. 
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CHAPTER VI 
DISCUSSION OF RESULTS 
The purpose of this study was to evaluate chlorpromazine ' s effects 
on visual sensitivity and intersensory phenomena produced in the visual 
sphere by auditory stimulation. The effects on visual functioning 
were measured by changes in CFF . 
A. Evaluation and Significance of Results 
The results indicated that some aspects of the visual sensory 
process as measured by CFF are affected by the drug chlorpromazine . 
The feasibility of using intersensory stimulation in a modified psycho-
physical method which is subject to quantification and replication for 
evaluating drug effects on a sensory process is supported b.f this study. 
A design using repeated measurements under all experimental conditions 
on the single subject was utilized in the present study. 
On the basis of data from Subject 1, it would appear that inter-
sensory functioning is modified in the presence of chlorpromazine . The 
operational hypothesis was confirmed and the findings indicated that 
the bipolar curve was heightened in the drug condition. The predicted 
intersensory effect also was observed in the placebo condition providmg 
a replication of prior research . Further, in the results with Subject 
1, the magnitude of the heteromodal effect during the drug period was 
enhanced across time . This suggested that a cumulative drug effect 
might be operating to increase the intersensory effect further . This 
suggestion was supported by the fact that a similar effect was not 
observed in the placebo period of Subject 1 . It, therefore, would 
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appear that chlorpromazine tends t o increase intersensory effects . This 
finding may be explained as follows . Within the context of MRN theory, 
chlorpromazine may have modified the biochemical environment in such 
manner that unimodal elements may be converted to MRN, or more frequent 
MRN firing may be permitted. These suggested actions are not inconsis-
tent with a chlorpromazine action demonstrated by Marrazzi (1957 b) . 
He showedthat chlorpromazine facilitated synaptic transmission . An 
alternate possibility is that the subliminal excitation of }ffiN was 
increased . In any case, with the introduction of tone, the MRN elements 
were activated and thus, perhaps, were associated with the heightened 
heteromodal effect . 
These findings must be considered withmution in view of the 
failure of Subject 2 to confirm the results of Subject 1 . Subject 2 
did not confirm the operational qypothesis . Further, he did not 
replicate the expected bipolar curve in the placebo condition. Neither 
did he show a significant cumulative effect in the drug condition. It 
should be noted that the drug produced a curve which, on inspection, 
was similar in shape to the predicted curve . However, this similarity 
was not verified by statistical analysis . The placebo curve showed 
fewer of the characteristics of the predicted function than did the 
drug curve . These finding~ in general, supported the directional drug 
effect notedwith chlorpromazine . 
The effects of chlorpromazine , if any, on visual sensitivity appear 
to have been obscured since both subjects improved in efficiency of 
function regardless of which condition occured first. It appeared that 
the changes noted in mean CFF thresholds in both subjects might best be 
explained as a practice effect. 
Finally, both subjects also demonstrated the inversion of the 
inhibition portion of the intersensory curve noted in former research. 
A possible explanation of the failure of Subject 2 to confirm 
the findings of prior research and of Subject 1 may be found in the 
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fact that he was a subject in the prior pilot study and was very highly 
trained in the performance of the experimental task. The possibility 
is suggested that Subject 2 was approaching what, for him, was a limit 
of his visual functioning. As a result, effects produced by the access-
ory stimulation or chlorpromazine may have been obscured. This proposal 
gains strength from an examination of the no-tone mean CFF thresholds 
shown in Figure 12. Subject 2 consistently demonstrated higher CFF 
and showed more efficient visual functioning than did Subject 1. This 
was true despite the fact that Subject 1 had superior visual acuity. 
There appear to be at least three other possibilities which might 
explain the discrepant findings of Subject 2 within the context of the 
MRN model. First, conceivably there could be more elements physio-
logically allocated to the sense modalities and fewer MRN available to 
function heteromodally. Such a condition would result in a flattening 
of the theoretical intersensory function, since there would be fewer MRN 
available to provide the facilitative and inhibitory heteromodal effect. 
A secord possibility requires a further assumption about MRN 
functioning~ we assume that the postulated MRN structure is affected 
by training, then it is possible that the results of Subject 2 may have 
been a function of participation in the prior pilot study . MRN elemerts 
may have been recruited into the functioning of the visual sense 
modality through the extensive prior training. This explanation is 
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consistent with the greater no-tone sensitivity observed in Subject 2 . 
It also might explain the absence of intersensory effects, for if many 
MRN were involed in basic sensory functioning, then few would be avail-
able to produce the diphasic manifestation of facilitation and inhibition . 
Finally, Subject 2 may have been relatively insensitive to audi-
tory stimulation. This would be reflected not in reduced acuity but in 
relative insensitivity and reduced responsivity . Perhaps people like 
Subject 2 in his jOb of welder, who are constantly exposed to loud 
sounds, become less sensitive to stimulation of this kind. It may be 
that a kind of habituation to increased sound might occur so that 
greater objective sound increase would be needed to produce a comparafie 
subjective experience in the "sound resistant" group . In MRN terms, a 
greater intensity of stimulation might be necessary to activate MRN 
elements, although the basic sensory elements would respond in a 
"normal" fashion. This might explain the differences between sensori-
ally sensitive and nonsensitive people. 
Further evidences of differences between the subjects were noted 
during the study . Subject l felt that the two loudest tones in the 
experiment were very loud and he perceived tone 7 as bordering on the 
painful. Subject 2 felt that these tones were loud but not especially 
so . While Subject 2 worked as a welder in a noisy shop, Subject l was 
a nurse in a relatively quiet atmosphere. Subject 2 was an excellent 
handball player and formerveight lifter and was quite outgoing. Subject 
1 was tall and very thin, engaged in intellectual pursuits, was 
introspective and sensitive to personal states and appeared to be an 
intellectual. 
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Kornetsky and Humphries (1957), and Di ~fuscio and Klerrnan (1960) 
demonstrated that people with different patterns of responding reacted 
differently to chlorpromazine. The latter investigators found that 
people whose personality focused around active mastery found drug action 
ego-threatening, while passive, intellectual subjects were more accept-
ing of drug effects . Subject 2 seemed closer to the active mastery 
groupvhile Subject l more nearly approximated a passive, intellectual 
subject . Subject l clearly demonstrated a drug effect; Subject 2 
yielded equivocal results . 
Finally, Subject 2 showed a rise under drug in diastolic blood 
pressure of about 15 percent while his systolic blood pressure remained 
relatively unchanged . Subject l showed no change in his blood pressure. 
The response of Subject 2 was contrary to reports in the literature of 
characteristic chlorpromazine action, which is to lower blood pressure. 
This finding tended to suggest again a differential response between 
the subjects . Since the blood pressure reaction of Subject 2 is not 
in agreement with results reported in the literature, it is suggested 
that Subject 2 may be an atypical subject . 
In any case, the inconsistency of findings in this research 
illustrates the problems and advantages implicit in a research design 
in which many responses are sampled fram a few subjects. The relative 
risk of getting a biased sample in some respects is enhanced. This 
difficulty could be circumvented, in part, by a larger sampling of 
subjects . 
B. Suggestions for Further Research 
Areas for further investigation include facets of both heteromodal 
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effects and chlorpromazine action. There is a hierarchy of functional 
impairment attributed to chlorpromazine . For example, motor function 
has been reported as being impaired before sensory function (Brodie 
1958) . However, the motor response often is a response to a sensory 
stimulus . Therefore, it would seem that further investigation of 
the effects of chlorpromazine on basic motor and sensory processes 
could profitably be carried out . The present research was designed 
to answer , in part, just such a question . The findings left 
this question unanswered since an apparent practice effect obscured 
the result of the drug on visual sensitivity as measured by CFF . 
Habituation and build up of the drug effects is another area 
of research which was raised by the present study. The results 
appeared to indicate the possibility of build up of drug effect . Yet 
some of the clinical descriptive literature spoke of habituation and 
need to increase dosage to maintain comparable drug effect . Clarifi-
cation of this issue would be useful . 
The problem of inter-subject variability could benefit from 
further exploration. In the present study sample of two, differences 
in drug effect were noted on intersensory function, on subjective 
experience, and on the physiological response of blood pressure . The 
literature also implied that different subjects react diff erently 
to chlorpromazine . Further research to elaborate the range of inter-
subject variability might prove rewarding. 
The area of differences in sensory responsivity also was raised 
by the present research. The possibility was stated that some people 
are more responsive to a sensory increase of unit size than others in 
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the pppulation. If this were so, then objectively equal increases of 
stimuli would produce effects which would differ from person to 
person. Perhaps to equate these people for experimental use, we 
would have to redefine the units of measurement used in terms of 
the individual subject ' s responsivity pattern. 
Finally, the present study also raised for investigation the 
issue of over-training . It was speculated that repeated and extensive 
exposure to a sensory task produced a rise in efficiency to a level 
so near maximum functioning that accessory stimulation produced effects 
which were negligible. If this were so, then the period of time that 
a single subject could be used in a repeated measurement design would 
have to be limited . 
CHAPTER VII 
SUMMARY AND CONCLUSIONS 
The purpose of the present study was to explore the effects of 
a tranquilizing drug, chlorpromazine , on visual sensitivity and 
intersensory effects produced by auditory stimulation in two normal 
subjects . The experiment was designed within the theoretical frame-
work of the mutually recruitable neuron, from which interpretive 
statemenwof observed drug effects might be drawn. 
The experimental literature on intersensory effects contains 
numerous studies in which stimulation of one sense modality 
produced a change in the sensitivity of another sense modality . 
There are reports of facilitation, inhibitio~ both facilitation and 
inhibition and neither . However, recent experiments within the area 
suggest that the sensitivity of the primary system first increases 
and then decreases as a function of the intensity of the accessory 
stimulation, resulting in facilitation and inhibition. 
The literature on sensory effects of chlorpromazine suggested 
varying effects that chlorpromazine appears to have. The direction 
and magnitude of the drug effects, however, seem to vary with kind 
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of subject, dosage, and task on which the measurement was made. The 
task selected for this experiment as an index of visual sensitivity 
was critical flicker fusion frequency . This t ask was selected because 
it has shown itself to be sensitive to changes in visual function 
associated with other drugs, such as evipan and nitrog,lycerine . 
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Further, CFF was thought to be r elatively unaffected by intelligence, 
repetition, or learning. Therefore, it was expected that any relation-
ship established between chlorpromazine and visual sensitivity and 
intersensory effects would be indicative of the drug effect on "normals" 
and would be applicable to the overall "normal" population within the 
limitations of individual differer£es. 
It was predicted that the bipolar effect on visual sensitivity 
which is associated with accessory auditory stimulation would be 
modified by chlorpromazine. It was assumed that the intersensory 
effect would appear under the placebo condition. This would be a 
replication of prior studies . It was necessary to demonstrate this 
relationship before the primary issue, the effect of chlorpromazine 
on intersensory functioning, could be dealt with . 
The plan of research also permitted assessment of visual sensi-
tivity in the absence of accessory stimulation. This aspect of the 
investigation was in the nature of empirical inquiry. 
The experimental subjects were two normal males, inmates of a 
correctional institution. Each provided a population of responses, 
and each response population was an entire experiment. The measure 
of visual sensitivity was critical flicker fusion frequency (CFF). 
The drug, chlorpromazine, in 100 mg. tablets, was matched with 
identical appearing placebos and each was administered for a co~tinu­
ous two week per iod. A double blind procedure was included so that 
only an outsider knew which period was the drug and which the placebo 
series . The accessory stimulation consisted of auditory stimulation 
binaurally administered. The accessory stimuli consisted of seven 
tones of increasing intensity but of a constant frequency, 1550 cycles 
per second . CFF thresholds were measured for each tonal intensity, 
and these observations were paired with the thresholds obtained 
immediately before without auditory stimulation. The observations 
consisted of 30 seconds of alternate ascending and descending CFF 
determinations under no-tone condition, followed by one minute of 
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rest , followed by 30 seconds of CFF observations under tone conditi on • . 
A two minute rest was then given. This was done for each tone on 
each day during both the chlorpromazine and placebo periods. 
The operational hypothesis for the experiment was stated as 
follows: The differences between mean CFF thresholds for the tone 
and no-tone conditions depend upon both tonal intensity and presence 
or absence of the dr ug, chlorpromazine. 
A further statement about the relationship of facilitation and 
inhibition to tonal intensity was predicted from prior research . 
It was expected that CFF would first increase and then decrease as 
the intensity of the tone increased. 
The data generated by each subject consisted of 280 means . These 
data were subjected to a four way classification analysis of variance 
(Edwards 1950) . 
The operational hypothesis could be supported only in the case 
of Subject 1 . Subject l replicated prior findings by demonstrating 
the heteromodal effect in the placebo condition. He showed a 
heightened intersensory effect under chlorpromazine, and evidenced 
increasing heteromodal effects under sustained medication. 
These findings were examined in terms of the MRN model . It was 
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felt that the enhanced heteromodal effect with chlorpromazine observed 
in Subject 1 might have been associated with a changed biochemical 
environment which then made possible an increase in the total pool 
of MRN or a greater frequency of MRN action. As an alternate 
possibility, it was proposed that the total MRN subliminally excited 
was increased so that with the ~dvent of accessory stimulation, 
greater intersensory effects were produced. 
Subject 2 did not..support the general hypothesis . He did not 
demonstrate the heteromodal effect in the placebo condition and 
thus failed to replicate prior research . In the drug condition, the 
data generated by Subject 2 pr oduced a curve which resembled the one 
predicted by intersensory theory . However, statistical analysis 
fail ed to achieve significance . 
The results produced by Subject 2 were examined. Subject 2 
had been a subject in a prior pilot study where he had been highLy 
trained on the apparatus used . It was proposed that Subject 2 was 
approaching what, for him, was a limit in his visual functioning, 
and thus any effects produced by accessory stimulation or drug were 
overridden or obscured. Within the MRN theory, it was posited that 
MRN might be affected by training and that some ~ffiN elements thus 
might have been "recruited" into the function of the basic sense 
modality. This would leave fewer MRN to enter into heteromodal actio~ 
An alternate possibility was offered which suggested that more 
elements might be physiologically allocated to the sense modalities 
in some people . As a result, fewer MRN would be available for inter-
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sensory action. 
Both subjects demonstrated an inversion of the heteromodal 
effects curve, as had prior research subjects . Further, both subjects 
showed an increase in visual efficiency across time in the no-tone 
condition. This occured even though Subject 1 received the drug 
during his first period and Subject 2 had the placebo initially. 
This suggested that changes in visual sensitivity might best be 
attributed to a practice effect . 
Individual differences between the subjects were discussed, and 
it was proposed that the two subjects represented two kinds of 
responding. The dangers of a few subject, many-response research 
design were discussed . Finally, suggestions for further research 
in the areas of intersensory effects and drug effects on sensory 
processes were offered. 
Conclusions which may be drawn from this study are limited by 
the results produced by Subject 2. The results of this subject are 
not inconsistent with, nor do t hey confirm, the findings of Subjec~ 
1 . Subject 1, meanwhile, does derive support for at least part of 
his performance from prior research in the field . The foll~~ing 
conclusions, therefore, are put forth tentatively and are based 
primarily on the results produced by Subject 1 . 
(l) The magnitude of intersensory effects, both facilitative 
and inhibitory, is enhanced in the presence of chlorpromazine. 
(2) The intersensory effects appear to increase as chlorpro-
mazine dosage is continued through time, suggesting a cumulative 
drug effect . 
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(3) Visual sensitivity, as measured by mean CFF, in the absence 
of auditory stimulation, appears to be affected by practice . This 
practice effect may have obscured the chlorpromazine action. 
(4) The theoretical model MRN made possible the generation of 
assumptions and explanatory statements which could account for the 
results of the two subjects . 
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Appendix A 
ANALYSES OF VARIANCE 
TABLE 1 
OVERALL ANALYSIS OF VARIANCE, SUBJECT 1 
SOURCE OF SUM OF d.f. MEAN 
VARIANCE SQUARES SQUARE 
Drug Condition 163.1447 1 163.1447 
Tone Condition 0.6557 1 0.6557 
Tone Level 65.0042 6 10.8340 
Day 57.1221 9 6.3469 
DC x TC 12.1848 1 12.1848 
DC X TL 36.6860 6 6.1143 
DC x D 35.5609 9 3.9512 
TC x TL 106.4807 6 17.7468 
TC X D 7.8940 9 0.8771 
TL x D 162.8971 54 3.0166 
DC X TC X TL 22.0483 6 3.6747 
DC X TC X D 2.8795 9 0.3199 
DC X TL X D 133.8337 54 2.4784 
TC x TL x D 63.7081 54 1.1798 
DC X TC X TL X D 69.8115 54 1.2929 
TOTAL 939.9153 279 
F 
126.19'** 
8.38'** 
4.91** 
9.42** 
4. 73'** 
3.06* 
13. 73** 
2.33** 
2.84* 
1.92* 
'** p < .01 
* p <. .05 
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TABLE 2 
ANALYSIS OF VARIANCE FOR PLACEBO CONDITION, SUBJECT 1 
SOURCE OF SUM OF d.f . MEAN 
VARIANCE SQUARES SQUARE 
TC ,3 . 59.36 1 .3 . 59.36 
TL 2.3 . 25.35 6 ,3 . 8756 
D 59 .7044 9 6. 6.3.38 
TC X TL 18.0127 6 .3.0021 
TC X D 5.86.39 9 0.6515 
TL X D 117.90.37 54 2.18.34 
TC X TL X D 68 • .34.31 54 1.2656 
TOTAL 296 .6748 1.39 
F 
2.84 
,3.06* 
5. 24** 
' 2 • .37* 
1. 7.3* 
** p < .01 
*P ( .05 
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TABLE 3 
ANALYSIS OF VARIANCE FOR DRUG CONDITION, SUBJECT 1 
SOURCE OF SUM OF d . f . MEAN 
VARIANCE SQUARES SQUARE 
TC 9.2469 1 9.2469 
TL 78.4367 6 13 .0728 
D 32.9786 9 3.6643 
TC X TL 110.5163 6 18.4194 
TC x D 4.9096 9 0.5455 
TL X D 178.8271 54 3.3116 
TC X TL X D 65.1805 54 1.2070 
TOTAL 480.0958 139 
F 
7.66* 
10.83** 
3.04* 
15 . 26** 
2. 74** 
** P(.01 
* P(.05 
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TABLE 4 
OVERALL ANALYSIS OF VARIANCE, SUBJECT 2 
SOURCE OF SUM OF d.f. MEAN 
VARIANCE SQUARES SQUARE 
Drug Condition 109.9382 l 109.9382 
Tone Condition 0.7770 l 0.7770 
Tone Level 8.7797 6 1.4633 
Day 58.4ll7 9 6.4902 
DC x TC 1.0358 l 1.0358 
DC x TL 10.3469 6 1.7245 
DC x D 41.8269 9 4.6474 
TC X TL 2.9434 6 0.4906 
TC X D 7.7673 9 0.8630 
TL X D 81.7375 54 1.5137 
DC X TC X T L 3.3574 6 0.5596 
DC X TC X D 3.2171 9 0.3575 
DC X TL X D 97.2282 54 1.8005 
TC X TL X D 53.8949 54 0.9981 
DC X TC X TL X D 59.6llO 54 1.1039 
TOTAL 540.8730 279 
F 
99.59** 
1.33 
5.88** 
1.56 
4.21** 
1.37 
1.63 
** P <.Ol 
* p < .05 
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TABLE 5 
ANALYSIS OF VARIANCE FOR PLACEBO CONDITION, SUBJECT 2 
SOURCE OF SUM OF 
VARIANCE SQUARES 
TC 0.0093 
TL 13.1474 
D 51.4318 
TC x TL 4.0070 
TC x D 4.9854 
TL x D 94.0655 
TC X TL X D 50.9708 
TOTAL 218.6173 
d.f. MEAN 
SQUARE 
1 0.0093 
6 2.1912 
9 5.7146 
6 0.6678 
9 0.5539 
54 1.7420 
54 0.9439 
139 
' 
F 
2.32-;1-
6.05** 
1.85* 
** p < .01 
* p < .05 
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TABLE 6 
ANALYSIS OF VARIANCE FOR DRUG CONDITION, SUBJECT 2 
SOURCE OF SUM OF 
VARIANCE SQUARES 
TC 1.8035 
TL 5.9792 
D 48.8068 
TC x TL 2.2938 
TC X D 5-9990 
TL x D 84.9002 
TC X TL X D 62.5351 
TOTAL 212.3174 
d.f. 
1 
6 
9 
6 
9 
54 
54 
139 
MEAN F 
SQUARE 
1.8035 1.56 
0.9965 
5.4230 4.68** 
0.3823 
0.6666 
1.5722 1.36 
1.1581 
** p < .01 
* p < .05 
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Appendix B 
DIFFERENCES BETWEEN NO-TONE MEAN CFF THRESHOLDS 
75 
TABLE 1 
MEAN CFF THRESHOLDS, NO-TONE, FIRST AND 
LAST TEN DAY PERIODS 
Days 1-10 Days 11- 20 Difference Sx -Sx t p 
Between 1 2 
Means 
Subject 1 39. 77* 40 . 88** 1.11 . 276 4 .02 < .01 
Subject 2 42 . 88-""* 44 .01* 1.13 .310 3.65 < . 01 
* Drug Condition 
** Placebo Condition 
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Appendix C 
INTENSITY OF TONAL STIMULATION 
TONES 
1 
2 
3 
4 
5 
6 
7 
TABLE 1 
INTENSITY OF TONES IN DECIBELS OVER 0.0002 DYNES/CM"AND 
IN VOLTS ACROSS OSCILLATOR TERMINALS 
DECIBElS 
77 
82 
86 
89 
91 
93 
96 
77 
VOLTAGE 
0.4 
1.1 
1.7 
2.5 
3.2 
4.0 
5.3 
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ABSTRACT 
The purpose of the present study was to explore the effects of a 
tranquilizing drug, chlorpromazine, on visual sensitivity and its 
modification in the presence of intersensory stimulation. The mutually 
recruitable neurone (MRN), a construct formulated in recent research on 
intersensory effects, provided a theoretical framework in which observed 
drug effects might be interpreted. 
Prior studies on intersensory effects have suggested that sensitiv-
ity in a primary sensory system first increases and then decreases as a 
function of the increasing intensity of the accessory stimulation, 
producing in turn both facilitation and inhibition. The literature on 
chlorpromazine has suggested that it might have effects on sensory 
processes but the magnitude and direction of these effects have varied 
with experimental conditions and there is need for further clarification. 
The present study was designed to investigate effects of chlorpro-
mazine on visual sensitivity in the presence of secondary auditory 
stimulation and to consider these effects in relation to predictions 
generated by MRN theory. 
General Hypothesis: Visual sensitivity, as measured by CFF thresholds, 
is a joint function of the intensity of auditory stimulation and the 
presence or absence of chlorpromazine. 
It was assumed that results would replicate prior research and 
demonstrate that facilitation and inhibition of visual sensitivity 
are a function of intensity of auditory stimulation. It was predicted 
that this relationship would be modified by chlorpromazine. 
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The measure of visual sensitivity was CFF, which was measured in 
a continuous recording of ascending and descending thresholds . Auditory 
stimulation consisted of seven increasing intensities of a 1550 cycles 
per second tone binaurally delivered . The CFF threshold under each 
tonal intensity was compared with a prior no-tone base line . Chlorpro-
mazine, 100 mg . per day, was administered for a two week period. The 
results obtained in the drug condition were compared with placebo data 
in a double blind design. The subjects were two psychiatrically normal 
volunteers . Either subject represents a complete experiment replicated 
by the other subject . 
The general hypothesis was clearly supported only in the case of 
one subject . The subject replicated prior findings by demonstrating 
the heteromodal effect in the placebo condition. He produced heightened 
intersensory effect with chlorpromazine and showed increasing hetero-
modal effect across time under drug, suggesting a possible build up of 
drug effect . The second subject did not support the general hypothesis , 
nor did he demonstrate the intersensory effect in the placebo condition. 
The curve produced by this subject in the drug condition, on inspection, 
suggested the predicted bipolar function, but statistical significance 
could not be demonstrated . Both subjects demonstrated an increase in 
visual efficiency across time in the no- tone condition despite the fact 
that one received the drug initially and the other placebo. This 
suggested the operation of a practice effect tending toward improved 
performance in visual threshold as measured by CFF . 
Considered in terms of MRN theory, the findings suggest the possi-
bility that chlorpromazine acts to break down neurological barrier~thus 
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increasing the MRN available or reducing the threshold of excitability 
for the postulated structure . The contrasting r esults from the two 
subjects suggest the importance of considering the individual differ-
ences in drug research . It was noted that the extensive training of 
Subject 2 in a pilot study and his continual exposure to occupational 
noise might , in part, account for his failure to confirm the expected 
relationship . The need for further study of individual factors was 
pointed out . 
It was tentatively concluded that heteromodal effects are 
enhanced in the presence of chlorpromazine and appear to increase with 
sustained medication over time . 
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